Biotech vaccine helps eliminate cervical cancer

Medical advances through biotechnology have long held much promise.  But now, that promise is becoming even more of a reality as a new vaccine has just been developed that could actually prevent over a quarter million female deaths per year.  According to science writer Michael Fumento, the biotech vaccine can protect against strains of the human papilloma virus which is thought to cause nearly three-quarters of all cervical cancer.  In the U.S., cervical cancer deaths have already decline dramatically due to pap smears and biopsies.  But in most countries which cannot afford such expensive preventative care, cervical cancer kills over 250,000 women each year, and after breast cancer, is the second leading cause of female cancer death.

Categories

About the Author: CFACT

CFACT defends the environment and human welfare through facts, news, and analysis.